Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
06/27/2013 | US20130164262 Recombinant Viruses and their Use for Treatment of Atherosclerosis and Othe Forms of Coronary Artery Disease and Method, Reagent, and Kit for Evaluating Susceptibiity to Same |
06/27/2013 | US20130164261 Substituted nucleotide analogs |
06/27/2013 | US20130164259 1,4-substituted piperazine derivatives and methods of use thereof |
06/27/2013 | US20130164258 Antiviral Compounds Composed of Three Aligned Aryl Moieties to Treat Diseases such as Hepatitis C |
06/27/2013 | US20130164255 Immunotherapy for reversing immune suppression |
06/27/2013 | US20130164252 Method for Hair Growth using Granulocyte-Colony Stimulating Factor |
06/27/2013 | US20130164250 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof |
06/27/2013 | CA2857968A1 Dosage regime for apolipoprotein formulations |
06/27/2013 | CA2855226A1 Novel jnk inhibitor molecules for treatment of various diseases |
06/27/2013 | CA2853779A1 Combination therapy with interferon and andrographolides for multiple sclerosis |
06/26/2013 | EP2607380A2 Fusion protein having transcription factor transactivation-regulating domain and protein transduction domain, and transcription factor function inhibitor comprising the same |
06/26/2013 | EP2607379A1 Variants derived from ActRIIB and uses therefor |
06/26/2013 | EP2607378A2 Methods for obtaining thermostable enzymes, DNA polymerase I variants from thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same |
06/26/2013 | EP2607374A1 Method for recombinant production of labyrinthopeptins and functional derivatives thereof |
06/26/2013 | EP2606908A1 Novel pharmaceutical composition for a long acting growth hormone fusion protein (LAGH) |
06/26/2013 | EP2606907A1 Optineurin-derived polypeptides, their nucleic acids and uses thereof |
06/26/2013 | EP2606906A1 Methods for administering anti-IL-5 antibodies |
06/26/2013 | EP2606905A1 Peptides targeting Receptor activator of nuclear factor-kappa B (RANK) and their applications |
06/26/2013 | EP2606904A1 Medicine or food supplement for treating and/or preventing joint ailments |
06/26/2013 | EP2606903A1 Polypeptide inhibitors of HSP27 kinase and uses therefor |
06/26/2013 | EP2606901A1 Neuregulin based methods and compositions for treating cardiovascular diseases |
06/26/2013 | EP2606899A1 High viscosity macromolecluar compositions for treating ocular conditions |
06/26/2013 | EP2606364A1 Tam receptors and tam receptor ligands in detection and modulation of neuropathological disease |
06/26/2013 | EP2606058A2 Peptide compounds to regulate the complement system |
06/26/2013 | EP2605790A2 Intranasal delivery of cell permeant therapeutics |
06/26/2013 | EP2605789A2 Modified relaxin polypeptides and their uses |
06/26/2013 | EP2605788A2 Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases |
06/26/2013 | EP2605787A2 Designer osteogenic proteins |
06/26/2013 | EP2605786A2 Therapeutic peptides |
06/26/2013 | EP2605763A1 Treatment |
06/26/2013 | EP2605755A1 Particulate substances comprising ceramic particles for delivery of biomolecules |
06/26/2013 | EP2605751A1 Phospholipid depot |
06/26/2013 | EP2311480B1 Compstatin analogs with improved activity |
06/26/2013 | CN103180439A Chimeric clotting factors |
06/26/2013 | CN103179980A Methods and compositions for cns delivery of iduronate-2-sulfatase |
06/26/2013 | CN103179979A Amide based glucagon superfamily peptide prodrugs |
06/26/2013 | CN103179978A Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2 |
06/26/2013 | CN103179977A Immunotherapeutic method for treating prostate cancer |
06/26/2013 | CN103179976A Glucagon superfamily peptides exhibiting g protein-coupled receptor activity |
06/26/2013 | CN103179974A New treatments of hepatitis c virus infection |
06/26/2013 | CN103179958A Method of preparing a dry powder from a water bacteria extract-concentrate |
06/26/2013 | CN103179951A Phospholipid depot |
06/26/2013 | CN103173477A Method for stably expressing recombined human serum albumin and human parathyroid hormone (1-34)ab diad fusion protein by using saccharomyces cerevisiae |
06/26/2013 | CN103173453A Application of lamprey Lj-RGD2 in preparation of anti-angiogenesis antitumour drug |
06/26/2013 | CN103172753A Fusion protein of GFE-1 and rmhTNF (recombinant mutant human Tumor Necrosis Factor) alpha and preparation method thereof |
06/26/2013 | CN103172751A Fusion protein of PA4-Fc and coding gene and application thereof |
06/26/2013 | CN103172750A Immunosuppressive polypeptides and nucleic acids |
06/26/2013 | CN103172748A Anti-malignant lymphoma fusion protein and preparation method thereof |
06/26/2013 | CN103172745A Long-acting human endothelium chalone containing immune globulin Fc segment |
06/26/2013 | CN103172742A Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
06/26/2013 | CN103172726A Secretin analogue, as well as preparation method and application thereof |
06/26/2013 | CN103172723A Rana margaratae antimicrobial peptide odorranain-H-OM1 as well as gene of coded sequence and application thereof |
06/26/2013 | CN103172722A Epinephelus coioides calmodulin gene, vector, recombinant strain and protein thereof, and application of protein |
06/26/2013 | CN103172721A Amolops hainanensis antimicrobial peptide Hainanenin-1, and gene, separation purification, chemical synthesis and application thereof |
06/26/2013 | CN103172720A Rana wuchuanensis antioxidant peptide wuchuanin-G, gene of coded sequence thereof and application of rana wuchuanensis antioxidant peptide wuchuanin-G |
06/26/2013 | CN103172706A Preparation method of chick-pea oligopeptide with antioxidation function |
06/26/2013 | CN103172699A 17beta-amino-11alpha-hydroxy-androsta-1,4-diene-3-ketone modified RGD tetrapeptide as well as synthesis and medical application thereof |
06/26/2013 | CN103172698A Antihypertensive polypeptides |
06/26/2013 | CN103169984A N-terminal derivatisation of proteins with polysaccharides |
06/26/2013 | CN103169980A Polyethylene glycol derivatives of antitumor small peptides FpAT |
06/26/2013 | CN103169970A Pharmaceutical composition for treating viral pneumonia |
06/26/2013 | CN103169957A Nano thrombin and preparation method thereof |
06/26/2013 | CN103169956A Drug for dispelling effects of alcohol and preventing anesthesia and production method thereof |
06/26/2013 | CN103169955A Chinese herbal medicine composition for preventing and treating heat stress of chickens |
06/26/2013 | CN103169954A A method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof |
06/26/2013 | CN103169953A Collagen peptide-colla corii asini oral solution and preparation method thereof |
06/26/2013 | CN103169952A Glucose sensitive film for performing controlled release of insulin |
06/26/2013 | CN103169951A Gel microcapsule with cell recruitment function and preparation method thereof |
06/26/2013 | CN103169950A BMP-2 (Bone Morphogenetic Protein-2) sustained release microsphere and preparation method thereof |
06/26/2013 | CN103169949A Pharmaceutical composition for treating or preventing ovarian cancer |
06/26/2013 | CN103169948A Regulation function of hepcidin regulatory protein to body immunity and application of hepcidin regulatory protein |
06/26/2013 | CN103169947A Reconstituted surfactants having improved properties |
06/26/2013 | CN103169946A Application of Safenour cyclopeptide in oral insulin medicine for treating diabetes |
06/26/2013 | CN103169945A Application of cyclopeptide in preparation of medicine for treating or preventing atherosclerosis |
06/26/2013 | CN103169944A Compound earthworm protein preparation for assistant adjustment of blood fat |
06/26/2013 | CN103169943A Anti-fatigue compound earthworm protein preparation |
06/26/2013 | CN103169942A Enzymolysis method for preparing velvet antler collagen |
06/26/2013 | CN103169699A Application of letrozole (LE) in preparation of drug used for causing adult cattle to excessively ovulate |
06/26/2013 | CN103169670A Acetic acid copaxone microsphere and preparation method thereof |
06/26/2013 | CN103169658A Preparation and application of fibroblast growth factor-10 (FGF-10) lipidosome in hair regrowth |
06/26/2013 | CN103168989A Lump sugar, as well as preparation method and application of lump sugar |
06/26/2013 | CN103168983A High-activity multi-nutrition active polypeptide for enhancing immunity |
06/26/2013 | CN102512669B Female whitening skin-nourishing composition |
06/26/2013 | CN102430129B Bone morphogenetic protein-2/basic fibroblast growth factor (BMP-2/bFGF) double-gene chitosan nano-microcapsules and application thereof |
06/26/2013 | CN102430110B CAlprostadil composite medicament of compound fermented cordyceps sinensis powder and alprostadil composite drug |
06/26/2013 | CN102268093B Fusion protein of hepatic-targeted peptide and human interferon a2b, and preparation method and application thereof |
06/26/2013 | CN102241759B Bacteriostatic ferritin and preparation and application thereof |
06/26/2013 | CN102241751B Novel fungal immunomodulatory protein FIP-NHA with antineoplastic activity and gene thereof |
06/26/2013 | CN102153655B Targeted anti-tumor recombinant protein and preparation method thereof |
06/26/2013 | CN102153630B Ring octapeptide and preparation method and application thereof in medicament making |
06/26/2013 | CN101883574B Periodontal bacterial growth inhibitor, oral hygiene product, and food and drink |
06/26/2013 | CN101505788B Prophylactic and/or therapeutic agents for peripheral neuropathy |
06/25/2013 | US8470976 Methods and compositions for targeting macromolecules into the nucleus |
06/25/2013 | US8470975 Collagen mixture and method of making the same |
06/25/2013 | US8470973 Modular DNA-binding domains and methods of use |
06/25/2013 | US8470969 Apo-2 ligand/trail formulations |
06/25/2013 | US8470968 SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same |
06/25/2013 | US8470967 Phase transition biopolymers and methods of use |
06/25/2013 | US8470964 Peptides derived from NCAM (FGLs) |
06/25/2013 | US8470891 Biodegradable block polymers for drug delivery, and methods related thereto |